AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2025
May 5, 2025
29745_dirs_2025-05-05_f10b8bbe-7e36-481f-8c9c-d7df84ed3ecd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-05-02
Reporting Person: Hakim Anat (EVP, GC & Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-02 | Common Stock | G | 17875 | — | Disposed | 10962.5 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 15700 | Indirect |
| Common Stock | 16875 | Indirect |
Footnotes
F1: On May 2, 2025, the Reporting Person transferred: (a) 1,000 shares of Eli Lilly and Company common stock to a spousal lifetime access trust, of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and children are beneficiaries; and (b) 16,875 shares of Eli Lilly and Company common stock to the reporting person's spouse.
F2: The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29